BJDX vs TDG · $5.0M cap vs P/E 41, rev $8.83B
Bluejay Diagnostics Inc (BJDX) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
BJDX does not have a complete income-statement cache yet.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
BJDX currently screens at market cap $5.0M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the BJDX and TDG stock pages for the full models.
Not investment advice.